Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company
By Jonathan Stempel (Reuters) -Warren Buffett's Berkshire Hathaway Inc said on Monday it eliminated its investment in Merck & Co and reduced its stakes in AbbVie Inc and Bristol-Myers Squibb Co, as it pared its overall stock market investments. Berkshire also eliminated its small stakes in Organon & Co, a Merck spinoff specializing in contraception and other women's health products, […]
Read more